Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Takeda Pharmaceutical ADR Rep 0.5 Ord Shs TAK

Healthcare
Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer)... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSE:TAK)

HUTCHMED Announces Launch by Takeda of FRUZAQLA® (fruquintinib) in Japan

GlobeNewswire 12 hours ago

New Survey Data Highlights the Importance of Prioritizing Mental Health for Canadians Living with IBD

Canada NewsWire November 4, 2024

HUTCHMED to Receive First Commercial Milestone Payment Following Over US$200 Million in FRUZAQLA® (fruquintinib) Sales by Takeda

GlobeNewswire October 31, 2024

Takeda Announces Strong First Half FY2024 Results and Raises Full Year Outlook

Business Wire October 31, 2024

Takeda and Boston Medical Center Announce Innovative Collaboration to Help Tackle Decarbonization Across Health Care Ecosystem

Business Wire October 24, 2024

HUTCHMED Announces Japan Approval for FRUZAQLA® (fruquintinib) Received by Takeda

GlobeNewswire September 24, 2024

Takeda Receives Approval for FRUZAQLA (fruquintinib) in Japan for the Treatment of Unresectable Advanced or Recurrent Colorectal Cancer

Business Wire September 24, 2024

Takeda to Present Additional Clinical Trial Study Data Highlighting the Impact of Orexin Agonist TAK-861 on the Burden of Narcolepsy at Sleep Europe 2024

Business Wire September 19, 2024

Takeda Commits Over $32 Million in Five New Global Corporate Social Responsibility Partnerships to Further Drive Health Impact in 93 Countries

Business Wire September 18, 2024
View More News ››

Opinion & Analysis (NYSE:TAK)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NYSE:TAK)

Takeda Presents Long-Term Data from Phase 3 ADVANCE-CIDP 3 C

Breaking News: $TAK Takeda Presents Long-Term Data from Phase 3 ADVANCE-CIDP 3 Clinical Trial of HYQVIA&#xAE; in Patients with...
whytestocks - June 18, 2024

Real stock price share value

4226$
Nibinator - November 14, 2023

colchicine vs covid

We got a new credible study out of Quebec. This drug is preventing: hospitalizations by 25%, the need for mechanical ventilation by 50%,...
GoldBrooke - January 25, 2021

Healthcare Stocks to Watch

There is a wide array of offerings from innovative care to advanced digital technologies from every corner of the market assessing just...
SHFeatureArticl - February 28, 2020
View more Bullboard ››

Innocan Pharma Corp

Innocan Pharma Corp

Innocan Pharma Corporation is an Israel-based company active in the pharmaceuticals and wellness sectors. In the ...
View More »